Ocular toxicity of intravitreal indocyanine green

San Ni Cheng, Te Cheng Yang, Jau Der Ho, Jiunn Feng Hwang, Cheng Kuo Cheng

研究成果: 雜誌貢獻文章

32 引文 (Scopus)

摘要

We report 6 cases of indocyanine green (ICG)-related ocular toxicity after intravitreal ICG usage. Five cases had preoperative diagnosis of macular hole, 1 case had preoperative rhegmatogenous retinal detachment complicated with proliferative vitreoretinopathy. All cases received vitrectomy, ICG-assisted internal limiting membrane (ILM) peeling and air-fluid exchange. All eyes had residual ICG left at the end of surgery. Patients were followed up with indirect ophthalmoscopy, visual acuity, color fundus photography, fluorescein angiography, and ocular coherence tomography. Circular foveal retinal pigment epithelium atrophy larger than the area of macular hole and surrounding cuff was noted in 4 of 5 cases with preoperative macular hole. The other eye with preoperative diagnosis of macular hole had shallow anterior chamber and low intraocular pressure lasting for 1 week postoperatively. Diffuse retinal pigment epithelial atrophy was noted in the eye with preoperative proliferative vitreoretinopathy. Four eyes demonstrated optic atrophy postoperatively. Ocular toxicity caused by ICG may present as pigment epithelial atrophy, which is characteristically larger than the previous area of macular hole and surrounding cuff. Disc atrophy, retinal toxicity, and ocular hypotony were also observed in some cases. To prevent toxicity, residual ICG and ICG-stained ILM must be removed as completely as possible.

原文英語
頁(從 - 到)85-93
頁數9
期刊Journal of Ocular Pharmacology and Therapeutics
21
發行號1
出版狀態已發佈 - 二月 2005

指紋

Indocyanine Green
Retinal Perforations
Atrophy
Proliferative Vitreoretinopathy
Ocular Hypotension
Optic Atrophy
Ophthalmoscopy
Retinal Pigments
Membranes
Retinal Pigment Epithelium
Fluorescein Angiography
Photography
Vitrectomy
Anterior Chamber
Retinal Detachment
Intraocular Pressure
Visual Acuity
Color
Air
Tomography

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Ophthalmology
  • Pharmacology, Toxicology and Pharmaceutics(all)

引用此文

Cheng, S. N., Yang, T. C., Ho, J. D., Hwang, J. F., & Cheng, C. K. (2005). Ocular toxicity of intravitreal indocyanine green. Journal of Ocular Pharmacology and Therapeutics, 21(1), 85-93.

Ocular toxicity of intravitreal indocyanine green. / Cheng, San Ni; Yang, Te Cheng; Ho, Jau Der; Hwang, Jiunn Feng; Cheng, Cheng Kuo.

於: Journal of Ocular Pharmacology and Therapeutics, 卷 21, 編號 1, 02.2005, p. 85-93.

研究成果: 雜誌貢獻文章

Cheng, SN, Yang, TC, Ho, JD, Hwang, JF & Cheng, CK 2005, 'Ocular toxicity of intravitreal indocyanine green', Journal of Ocular Pharmacology and Therapeutics, 卷 21, 編號 1, 頁 85-93.
Cheng, San Ni ; Yang, Te Cheng ; Ho, Jau Der ; Hwang, Jiunn Feng ; Cheng, Cheng Kuo. / Ocular toxicity of intravitreal indocyanine green. 於: Journal of Ocular Pharmacology and Therapeutics. 2005 ; 卷 21, 編號 1. 頁 85-93.
@article{23a42bdc28224ac0a784b7da3be7cbc6,
title = "Ocular toxicity of intravitreal indocyanine green",
abstract = "We report 6 cases of indocyanine green (ICG)-related ocular toxicity after intravitreal ICG usage. Five cases had preoperative diagnosis of macular hole, 1 case had preoperative rhegmatogenous retinal detachment complicated with proliferative vitreoretinopathy. All cases received vitrectomy, ICG-assisted internal limiting membrane (ILM) peeling and air-fluid exchange. All eyes had residual ICG left at the end of surgery. Patients were followed up with indirect ophthalmoscopy, visual acuity, color fundus photography, fluorescein angiography, and ocular coherence tomography. Circular foveal retinal pigment epithelium atrophy larger than the area of macular hole and surrounding cuff was noted in 4 of 5 cases with preoperative macular hole. The other eye with preoperative diagnosis of macular hole had shallow anterior chamber and low intraocular pressure lasting for 1 week postoperatively. Diffuse retinal pigment epithelial atrophy was noted in the eye with preoperative proliferative vitreoretinopathy. Four eyes demonstrated optic atrophy postoperatively. Ocular toxicity caused by ICG may present as pigment epithelial atrophy, which is characteristically larger than the previous area of macular hole and surrounding cuff. Disc atrophy, retinal toxicity, and ocular hypotony were also observed in some cases. To prevent toxicity, residual ICG and ICG-stained ILM must be removed as completely as possible.",
author = "Cheng, {San Ni} and Yang, {Te Cheng} and Ho, {Jau Der} and Hwang, {Jiunn Feng} and Cheng, {Cheng Kuo}",
year = "2005",
month = "2",
language = "English",
volume = "21",
pages = "85--93",
journal = "Journal of Ocular Pharmacology and Therapeutics",
issn = "1080-7683",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Ocular toxicity of intravitreal indocyanine green

AU - Cheng, San Ni

AU - Yang, Te Cheng

AU - Ho, Jau Der

AU - Hwang, Jiunn Feng

AU - Cheng, Cheng Kuo

PY - 2005/2

Y1 - 2005/2

N2 - We report 6 cases of indocyanine green (ICG)-related ocular toxicity after intravitreal ICG usage. Five cases had preoperative diagnosis of macular hole, 1 case had preoperative rhegmatogenous retinal detachment complicated with proliferative vitreoretinopathy. All cases received vitrectomy, ICG-assisted internal limiting membrane (ILM) peeling and air-fluid exchange. All eyes had residual ICG left at the end of surgery. Patients were followed up with indirect ophthalmoscopy, visual acuity, color fundus photography, fluorescein angiography, and ocular coherence tomography. Circular foveal retinal pigment epithelium atrophy larger than the area of macular hole and surrounding cuff was noted in 4 of 5 cases with preoperative macular hole. The other eye with preoperative diagnosis of macular hole had shallow anterior chamber and low intraocular pressure lasting for 1 week postoperatively. Diffuse retinal pigment epithelial atrophy was noted in the eye with preoperative proliferative vitreoretinopathy. Four eyes demonstrated optic atrophy postoperatively. Ocular toxicity caused by ICG may present as pigment epithelial atrophy, which is characteristically larger than the previous area of macular hole and surrounding cuff. Disc atrophy, retinal toxicity, and ocular hypotony were also observed in some cases. To prevent toxicity, residual ICG and ICG-stained ILM must be removed as completely as possible.

AB - We report 6 cases of indocyanine green (ICG)-related ocular toxicity after intravitreal ICG usage. Five cases had preoperative diagnosis of macular hole, 1 case had preoperative rhegmatogenous retinal detachment complicated with proliferative vitreoretinopathy. All cases received vitrectomy, ICG-assisted internal limiting membrane (ILM) peeling and air-fluid exchange. All eyes had residual ICG left at the end of surgery. Patients were followed up with indirect ophthalmoscopy, visual acuity, color fundus photography, fluorescein angiography, and ocular coherence tomography. Circular foveal retinal pigment epithelium atrophy larger than the area of macular hole and surrounding cuff was noted in 4 of 5 cases with preoperative macular hole. The other eye with preoperative diagnosis of macular hole had shallow anterior chamber and low intraocular pressure lasting for 1 week postoperatively. Diffuse retinal pigment epithelial atrophy was noted in the eye with preoperative proliferative vitreoretinopathy. Four eyes demonstrated optic atrophy postoperatively. Ocular toxicity caused by ICG may present as pigment epithelial atrophy, which is characteristically larger than the previous area of macular hole and surrounding cuff. Disc atrophy, retinal toxicity, and ocular hypotony were also observed in some cases. To prevent toxicity, residual ICG and ICG-stained ILM must be removed as completely as possible.

UR - http://www.scopus.com/inward/record.url?scp=14044263558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14044263558&partnerID=8YFLogxK

M3 - Article

C2 - 15718832

AN - SCOPUS:14044263558

VL - 21

SP - 85

EP - 93

JO - Journal of Ocular Pharmacology and Therapeutics

JF - Journal of Ocular Pharmacology and Therapeutics

SN - 1080-7683

IS - 1

ER -